Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic…
Springer International Publishing
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
| Title |
Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria
|
|---|---|
| Published by |
Springer International Publishing, January 2021
|
| DOI | 10.1007/978-3-030-74173-0 |
| ISBNs |
978-3-03-074172-3, 978-3-03-074173-0
|
| Authors |
Stefan Pieper |
X Demographics
The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 4 | 17% |
| United Kingdom | 3 | 13% |
| Switzerland | 2 | 8% |
| Spain | 1 | 4% |
| Italy | 1 | 4% |
| Netherlands | 1 | 4% |
| Belgium | 1 | 4% |
| Unknown | 11 | 46% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 21 | 88% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Scientists | 1 | 4% |